Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8598253, 19 pages
http://dx.doi.org/10.1155/2016/8598253
Review Article

Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review

1Department of Physical Education & Sport Science, University of Thessaly, Karyes, 421 00 Trikala, Greece
2Department of Kinesiology, Institute for Research and Technology-CERTH, Thessaly, Karyes, 421 00 Trikala, Greece
3School of Sports, Performing Arts & Leisure, University of Wolverhampton, Wolverhampton WV1 1LY, UK
4Department of Physical Education & Sport Science, National and Kapodistrian University of Athens, 172 37 Athens, Greece
5Department of Nephrology, School of Medicine, University of Thessaly, 411 10 Larissa, Greece
6Faculty of Sport and Health Sciences, University of St Mark and St John, Plymouth PL6 8BH, UK

Received 22 March 2016; Revised 31 May 2016; Accepted 7 June 2016

Academic Editor: Joachim Jankowski

Copyright © 2016 Konstantina P. Poulianiti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Bayés, M. C. Pastor, J. Bonal, A. Foraster, and R. Romero, “Oxidative stress, inflammation and cardiovascular mortality in haemodialysis—role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up,” Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 984–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Stenvinkel and P. Bárány, “Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress,” Nephrology Dialysis Transplantation, vol. 17, supplement 5, pp. 32–37, 2002. View at Google Scholar · View at Scopus
  3. H. Terawaki, K. Yoshimura, T. Hasegawa et al., “Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin,” Kidney International, vol. 66, no. 5, pp. 1988–1993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. I. C. Macdougall and A. Cooper, “The inflammatory response and epoetin sensitivity,” Nephrology Dialysis Transplantation, vol. 17, supplement 1, pp. 48–52, 2002. View at Google Scholar · View at Scopus
  5. T. Grune, O. Sommerburg, and W. G. Siems, “Oxidative stress in anemia,” Clinical Nephrology, vol. 53, supplement 1, pp. S18–S22, 2000. View at Google Scholar · View at Scopus
  6. E. O. Gosmanova and N.-A. Le, “Cardiovascular complications in CKD patients: role of oxidative stress,” Cardiology Research and Practice, vol. 2011, Article ID 156326, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Drüeke, V. Witko-Sarsat, Z. Massy et al., “Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease,” Circulation, vol. 106, no. 17, pp. 2212–2217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. X.-B. Yang, F.-F. Hou, Q. Wu et al., “Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease,” Zhonghua Nei Ke Za Zhi, vol. 44, no. 5, pp. 342–346, 2005. View at Google Scholar · View at Scopus
  9. T. Shoji, E. Kimoto, K. Shinohara et al., “The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients,” Kidney International Supplements, vol. 63, no. 84, pp. S128–S130, 2003. View at Google Scholar · View at Scopus
  10. A. Ayala, M. F. Muñoz, and S. Argüelles, “Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 360438, 31 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Peuchant, M.-C. Delmas-Beauvieux, L. Dubourg et al., “Antioxidant effects of a supplemented very low protein diet in chronic renal failure,” Free Radical Biology and Medicine, vol. 22, no. 1-2, pp. 313–320, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Ceballos-Picot, V. Witko-Sarsat, M. Merad-Boudia et al., “Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure,” Free Radical Biology and Medicine, vol. 21, no. 6, pp. 845–853, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Ross, L. C. Koo, and J. B. Moberly, “Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients,” American Journal of Kidney Diseases, vol. 30, no. 4, pp. 489–494, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. R. K. Sindhu, A. Ehdaie, F. Farmand et al., “Expression of catalase and glutathione peroxidase in renal insufficiency,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1743, no. 1-2, pp. 86–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Wilcox, “Redox regulation of the afferent arteriole and tubuloglomerular feedback,” Acta Physiologica Scandinavica, vol. 179, no. 3, pp. 217–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, and C. Wanner, “Inflammation enhances cardiovascular risk and mortality in hemodialysis patients,” Kidney International, vol. 55, no. 2, pp. 648–658, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Hensley, K. A. Robinson, S. P. Gabbita, S. Salsman, and R. A. Floyd, “Reactive oxygen species, cell signaling, and cell injury,” Free Radical Biology and Medicine, vol. 28, no. 10, pp. 1456–1462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-I. Yamagishi, Y. Inagaki, T. Okamoto et al., “Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells,” The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20309–20315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. P. C. Grooteman, J. C. Bos, A. J. Van Houte, J. Van Limbeck, M. Schoorl, and M. J. Nubé, “Mechanisms of intra-dialyser granulocyte activation: a sequential dialyser elution study,” Nephrology Dialysis Transplantation, vol. 12, no. 3, pp. 492–499, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Morena, J.-P. Cristol, and B. Canaud, “Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance,” Blood Purification, vol. 18, no. 3, pp. 191–199, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Miyazaki, H. Matsuoka, H. Itabe et al., “Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer,” Circulation, vol. 101, no. 9, pp. 1002–1006, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Nourooz-Zadeh, “Effect of dialysis on oxidative stress in uraemia,” Redox Report, vol. 4, no. 1-2, pp. 17–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Canaud, J.-P. Cristol, M. Morena, H. Leray-Moragues, J.-Y. Bosc, and F. Vaussenat, “Imbalance of oxidants and antioxidants in haemodialysis patients,” Blood Purification, vol. 17, no. 2-3, pp. 99–106, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Book Series, The Cochrane Collaboration and John Wiley & Sons Ltd, New York, NY, USA, 2008.
  25. D. Moher, A. Liberati, J. Tetzlaff et al., “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, pp. 264–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. National Guideline Clearinghouse, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” March 2016, https://www.guideline.gov/content.aspx?id=46510.
  27. N. Sahni, K. L. Gupta, S. V. Rana, R. Prasad, and A. K. Bhalla, “Intake of antioxidants and their status in chronic kidney disease patients,” Journal of Renal Nutrition, vol. 22, no. 4, pp. 389–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E. C. Papavasiliou, C. Gouva, K. C. Siamopoulos, and A. D. Tselepis, “Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin,” Kidney International, vol. 68, no. 1, pp. 246–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Bober, K. Kedzierska, E. Kwiatkowska et al., “Does oxidative stress affect the activity of the sodium-proton exchanger?” Annales Academiae Medicae Stetinensis, vol. 56, no. 3, pp. 5–12, 2010. View at Google Scholar · View at Scopus
  30. J.-Y. Choi, Y. J. Yoon, H.-J. Choi et al., “Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis,” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1304–1313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Yawata and H. S. Jacob, “Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its persistence despite adequate hemodialysis,” Blood, vol. 45, no. 2, pp. 231–239, 1975. View at Google Scholar · View at Scopus
  32. R. Schiavon, G. C. Guidi, S. Biasioli, E. De Fanti, and L. Targa, “Plasma glutathione peroxidase activity as an index of renal function,” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 32, no. 10, pp. 759–765, 1994. View at Google Scholar
  33. A. S. Yalçin, M. Yurtkuran, K. Dilek, A. Kilinç, Y. Taga, and K. Emerk, “The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients,” Clinica Chimica Acta, vol. 185, no. 1, pp. 109–112, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ganguli, H. S. Kohli, M. Khullar, K. Lal Gupta, V. Jha, and V. Sakhuja, “Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease,” Renal Failure, vol. 31, no. 2, pp. 106–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Marsillach, A. Martínez-Vea, L. Marcas et al., “Administration of exogenous erythropoietin β affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 4, pp. 347–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. F. Ramos, J. Kane, E. McMonagle et al., “Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease,” Journal of Renal Nutrition, vol. 21, no. 3, pp. 211–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. Moreillon, R. G. Bowden, E. Deike et al., “The use of an anti-inflammatory supplement in patients with chronic kidney disease,” Journal of Complementary & Integrative Medicine, vol. 10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. L. J. Roberts II, J. A. Oates, M. F. Linton et al., “The relationship between dose of vitamin E and suppression of oxidative stress in humans,” Free Radical Biology & Medicine, vol. 43, no. 10, pp. 1388–1393, 2007. View at Google Scholar
  39. H. Hatcher, R. Planalp, J. Cho, F. M. Torti, and S. V. Torti, “Curcumin: from ancient medicine to current clinical trials,” Cellular and Molecular Life Sciences, vol. 65, no. 11, pp. 1631–1652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Gupta, A. Parihar, P. Malhotra et al., “Effects of gum resin of Boswellia serrata in patients with chronic colitis,” Planta Medica, vol. 67, no. 5, pp. 391–395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Madisch, S. Miehlke, O. Eichele et al., “Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial,” International Journal of Colorectal Disease, vol. 22, no. 12, pp. 1445–1451, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Bishu and R. Agarwal, “Acute injury with intravenous iron and concerns regarding long-term safety,” Clinical Journal of the American Society of Nephrology, vol. 1, supplement 1, pp. S19–S23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, “The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia,” Kidney International, vol. 62, no. 5, pp. 1524–1538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Sommerburg, T. Grune, H. Hampl et al., “Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?” Nephrology Dialysis Transplantation, vol. 13, no. 10, pp. 2583–2587, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Triolo, M. Malaguti, F. Ansali et al., “Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 31, no. 2, pp. 185–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Sakata, R. Furuya, T. Shimazu, M. Odamaki, S. Ohkawa, and H. Kumagai, “Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients,” Blood Purification, vol. 26, no. 4, pp. 371–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. M. Dimitrijevic, T. P. Cvetkovic, V. M. Djordjevic et al., “How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients,” International Journal of Medical Sciences, vol. 9, no. 9, pp. 808–815, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-H. Guo, P.-C. Chen, G.-S. W. Hsu, and C.-L. Wang, “Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study,” Nutrients, vol. 5, no. 4, pp. 1456–1470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Haklar, I. Yegenaga, and A. S. Yalçin, “Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters,” Clinica Chimica Acta, vol. 234, no. 1-2, pp. 109–114, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Dolegowska, J. Stepniewska, K. Ciechanowski et al., “Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure?” Blood Purification, vol. 25, no. 5-6, pp. 422–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Mera, M. Anraku, K. Kitamura, K. Nakajou, T. Maruyama, and M. Otagiri, “The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst,” Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1322–1328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Anraku, K. Kitamura, A. Shinohara et al., “Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients,” Kidney International, vol. 66, no. 2, pp. 841–848, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. Ward, R. Ouseph, and K. R. McLeish, “Effects of high-flux hemodialysis on oxidant stress,” Kidney International, vol. 63, no. 1, pp. 353–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Fragedaki, M. Nebel, N. Schupp et al., “Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis,” Nephrology Dialysis Transplantation, vol. 20, no. 9, pp. 1936–1943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Stepniewska, B. Dolegowska, K. Ciechanowski, E. Kwiatkowska, B. Millo, and D. Chlubek, “Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions,” Archives of Medical Research, vol. 37, no. 3, pp. 353–359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Morena, S. Delbosc, A.-M. Dupuy, B. Canaud, and J.-P. Cristol, “Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation,” Hemodialysis International, vol. 9, no. 1, pp. 37–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. A. R. Migliaccio, “A niche for every cell, for every function,” Haematologica, vol. 98, no. 11, pp. 1660–1663, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Praticò, L. Iuliano, A. Mauriello et al., “Localization of distinct F2-isoprostanes in human atherosclerotic lesions,” The Journal of Clinical Investigation, vol. 100, no. 8, pp. 2028–2034, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. J.-L. Cracowski, C. Souvignet, N. Quirin et al., “Urinary F2-isoprostanes formation in kidney transplantation,” Clinical Transplantation, vol. 15, no. 1, pp. 58–62, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. L. J. Roberts II and J. D. Morrow, “Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation,” Cellular and Molecular Life Sciences, vol. 59, no. 5, pp. 808–820, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. J. D. Morrow, K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, and L. J. Roberts II, “A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 23, pp. 9383–9387, 1990. View at Publisher · View at Google Scholar · View at Scopus
  62. S. A. Dillon, G. M. Lowe, D. Billington, and K. Rahman, “Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F2α in smoking and nonsmoking men and women,” Journal of Nutrition, vol. 132, no. 2, pp. 168–171, 2002. View at Google Scholar · View at Scopus
  63. G. Cao, R. L. Prior, R. G. Cutler, and B. P. Yu, “Effect of dietary restriction on serum antioxidant capacity in rats,” Archives of Gerontology and Geriatrics, vol. 25, no. 3, pp. 245–253, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Pakfetrat, L. Malekmakan, and M. Hasheminasab, “Diminished selenium levels in hemodialysis and continuous ambulatory peritoneal dialysis patients,” Biological Trace Element Research, vol. 137, no. 3, pp. 335–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Avissar, D. B. Ornt, Y. Yagil et al., “Human kidney proximal tubules are the main source of plasma glutathione peroxidase,” The American Journal of Physiology—Cell Physiology, vol. 266, no. 2, part 1, pp. C367–C375, 1994. View at Google Scholar · View at Scopus
  66. H. Zumkley, H. P. Bertram, and A. Lison, “Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency,” Clinical Nephrology, vol. 12, no. 1, pp. 18–21, 1979. View at Google Scholar · View at Scopus
  67. V. Schettler, E. Wieland, H. Methe, P. Schuff-Werner, and G. A. Müller, “Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes,” Nephrology Dialysis Transplantation, vol. 13, no. 10, pp. 2588–2593, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Romeu, R. Nogues, L. Marcas et al., “Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study,” BMC Research Notes, vol. 3, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. I. Ceballos, P. Chauveau, V. Guerin et al., “Early alterations of plasma free amino acids in chronic renal failure,” Clinica Chimica Acta, vol. 188, no. 2, pp. 101–108, 1990. View at Publisher · View at Google Scholar · View at Scopus
  70. P. S. Ogunro, F. A. Olujombo, M. O. Ajala, and T. T. Oshodi, “The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease,” Saudi Journal of Kidney Diseases and Transplantation, vol. 25, no. 6, pp. 1186–1193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Trimarchi, M. R. Mongitore, P. Baglioni et al., “N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients—a pilot study,” Clinical Nephrology, vol. 59, no. 6, pp. 441–446, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Ramos and A. Martínez-Castelao, “Lipoperoxidation and hemodialysis,” Metabolism: Clinical and Experimental, vol. 57, no. 10, pp. 1369–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. K. S. Smith, C.-L. Lee, J. W. Ridlington, S. W. Leonard, S. Devaraj, and M. G. Traber, “Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients,” Lipids, vol. 38, no. 8, pp. 813–819, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Malindretos, P. A. Sarafidis, I. Rudenco et al., “Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran,” American Journal of Nephrology, vol. 27, no. 6, pp. 572–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Westhuyzen, D. Saltissi, and V. Stanbury, “Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane,” Annals of Clinical and Laboratory Science, vol. 33, no. 1, pp. 3–10, 2003. View at Google Scholar · View at Scopus
  76. K.-C. Huang, C.-C. Yang, S.-P. Hsu et al., “Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients,” Kidney International, vol. 70, no. 2, pp. 391–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Fumeron, T. Nguyen-Khoa, C. Saltiel et al., “Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 20, no. 9, pp. 1874–1879, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Washio, M. Inagaki, M. Tsuji et al., “Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker,” Nephron Clinical Practice, vol. 109, no. 2, pp. c49–c54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. D.-C. Tarng, T.-Y. Liu, and T.-P. Huang, “Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients,” Kidney International, vol. 66, no. 2, pp. 820–831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Himmelfarb, T. Alp Ikizler, C. Ellis et al., “Provision of antioxidant therapy in hemodialysis (Path): a randomized clinical trial,” Journal of the American Society of Nephrology, vol. 25, no. 3, pp. 623–633, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. I. G. Fatouros, I. Douroudos, S. Panagoutsos et al., “Effects of L-carnitine on oxidative stress responses in patients with renal disease,” Medicine and Science in Sports and Exercise, vol. 42, no. 10, pp. 1809–1818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Deicher and W. H. Hörl, “Vitamin C in chronic kidney disease and hemodialysis patients,” Kidney and Blood Pressure Research, vol. 26, no. 2, pp. 100–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Deicher, F. Ziai, C. Bieglmayer, M. Schillinger, and W. H. Hörl, “Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients,” Journal of the American Society of Nephrology, vol. 16, no. 6, pp. 1811–1818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Kaikkonen, E. Porkkala-Sarataho, J. D. Morrow et al., “Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men,” Free Radical Research, vol. 35, no. 6, pp. 967–978, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. H.-Y. Huang, L. J. Appel, K. D. Croft, E. R. Miller III, T. A. Mori, and I. B. Puddey, “Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial,” American Journal of Clinical Nutrition, vol. 76, no. 3, pp. 549–555, 2002. View at Google Scholar · View at Scopus
  86. F. Afaq, P. Abidi, and Q. Rahman, “N-acetyl l-cysteine attenuates oxidant-mediated toxicity induced by chrysotile fibers,” Toxicology Letters, vol. 117, no. 1-2, pp. 53–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. O. I. Aruoma, B. Halliwell, B. M. Hoey, and J. Butler, “The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid,” Free Radical Biology and Medicine, vol. 6, no. 6, pp. 593–597, 1989. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Vendemiale, I. Grattagliano, M. L. Caruso et al., “Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-α,” Toxicology and Applied Pharmacology, vol. 175, no. 2, pp. 130–139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. F. Canestrari, U. Buoncristiani, F. Galli et al., “Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients,” Clinica Chimica Acta, vol. 234, no. 1-2, pp. 127–136, 1995. View at Publisher · View at Google Scholar · View at Scopus
  90. B. González-Diez, M. Cavia, G. Torres, P. Abaigar, V. Camarero, and P. Muñiz, “The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure,” Molecular Biology Reports, vol. 39, no. 1, pp. 629–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Imani, H. Tabibi, S. Atabak, L. Rahmani, M. Ahmadinejad, and M. Hedayati, “Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients,” Journal of Renal Nutrition, vol. 19, no. 5, pp. 389–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Dawson and M. Walters, “Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?” British Journal of Clinical Pharmacology, vol. 62, no. 6, pp. 633–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. J.-W. Jung, D.-K. Kim, H.-W. Park et al., “An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing,” Genetics in Medicine, vol. 17, no. 10, pp. 807–814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. T. Akimoto, Y. Morishita, C. Ito et al., “Febuxostat for hyperuricemia in patients with advanced chronic kidney disease,” Drug Target Insights, vol. 8, pp. 39–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Jamilian and Z. Asemi, “The effect of soy intake on metabolic profiles of women with gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 12, pp. 4654–4661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Hariri, R. Salehi, A. Feizi, M. Mirlohi, R. Ghiasvand, and N. Habibi, “A randomized, double-blind, placebo-controlled, clinical trial on probiotic soy milk and soy milk: effects on epigenetics and oxidative stress in patients with type II diabetes,” Genes and Nutrition, vol. 10, no. 6, article 52, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Rowley, K. O'Dea, Q. Su, A. J. Jenkins, and J. D. Best, “Low plasma concentrations of diet-derived antioxidants in association with microalbuminuria in Indigenous Australian populations,” Clinical Science, vol. 105, no. 5, pp. 569–575, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Himmelfarb, J. Kane, E. McMonagle et al., “Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease,” Kidney International, vol. 64, no. 3, pp. 978–991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. M. J. Bek, S. Wahle, B. Müller et al., “Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes,” The FASEB Journal, vol. 17, no. 6, pp. 682–684, 2003. View at Google Scholar · View at Scopus
  100. R. Ardaillou, D. Chansel, C. Chatziantoniou, and J.-C. Dussaule, “Mesangial AT1 receptors: expression, signaling, and regulation,” Journal of the American Society of Nephrology, vol. 10, no. 1, pp. S40–S46, 1999. View at Google Scholar · View at Scopus
  101. S. Higueruelo and R. Romero, “Angiotensin II requires PDGF-BB to induce DNA synthesis in rat mesangial cells cultured in an exogenous insulin-free medium,” Nephrology Dialysis Transplantation, vol. 12, no. 4, pp. 694–700, 1997. View at Publisher · View at Google Scholar · View at Scopus
  102. G. Ding, A. Zhang, S. Huang et al., “ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR,” The American Journal of Physiology—Renal Physiology, vol. 293, no. 6, pp. F1889–F1897, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. S. K. Mallipattu and J. C. He, “The beneficial role of retinoids in glomerular disease,” Frontiers in Medicine, vol. 2, article 16, 2015. View at Publisher · View at Google Scholar